Page 93 - Read Online
P. 93

Page 6 of 11        Avvedimento et al. Mini-invasive Surg 2022;6:24  https://dx.doi.org/10.20517/2574-1225.2021.143

               Given these considerations, in redo-TAVI, a tailored screening on the risk of coronary obstruction is
               strongly recommended. It should be carefully performed in each patient and achieved through dedicated
               pre-procedural CT and fluoroscopic imaging analysis.


               ACHIEVING COMMISSURAL ALIGNMENT WITH DIFFERENT THV TYPES
               Patient-specific alignment of TAVI devices is nowadays allowed by pre-procedural CT analysis, performed
               not only to identify the coplanar implant view but also to add anatomical information about coronary ostia
               orientation and native commissures. CT-based commissural alignment can be planned, aiming to identify
               specific fluoroscopic projection or predicting TAVI system axial rotation. The Alignment of Transcatheter
               Aortic-Valve Neo-Commissures (ALIGN TAVR) study first evaluated the impact of initial THV
               deployment orientation on neo-commissural overlap with coronary arteries [19,20] . Afterwards, other studies
               have extensively addressed this issue.


               In this section, we provide a summary of available data for the main types of TAVI devices.

               Self-expanding THVs
               The importance of commissural alignment during self-expandable THV implantation is highlighted above.
               In the ALIGN TAVR study, 828 TAVR implants (SAPIEN 3, 483; Evolut, 245; ACURATE-neo, 100) were
               analyzed using pre-procedural multidetector row CT and coplanar fluoroscopy coregistration. Significantly
               less severe coronary overlap was obtained according to the precise positioning of the Hat marker of
               CoreValve Evolut that can be oriented in one of four positions: anterior or posterior in the center of the
               deployment device [center front (CF) or center back (CB)] or in the inner (IC) or outer curve (OC) of the
               aortic annulus [Figure 4].


               A Hat marker is a radiopaque marker at the distal part of the delivery catheter, located at an angle of 90° to
               the right from the C-tab, that is aligned with one of the commissures and with the flush port. Evolut Hat
               position at OC or CF during initial deployment improved commissural alignment and reduced the rate of
               coronary artery overlap (from 36% to 60%; P < 0.05) compared to Hat marker positioned toward the IC or
               CB. Furthermore, the best rate of right orientation of the Hat marker was obtained positioning Evolut flush
                                      [21]
               port at 3 o’clock [Figure 5] . This maneuver can be performed during initial insertion in the femoral artery
               as the rotation of the delivery system is limited inside the patient, given there are two spines within the
               Evolut catheter. In fact, we accumulated over 450 consecutive case experiences with the Evolut THV
               platform using this insertion technique from March 2019 and from January 2020 to July 2021. Among 316
               Evolut TAVI cases, we were able to get the Hat position to the outer curve or center front 96.8% of the time.
               However, some limitations regarding flush port positioning have been reported: other approaches different
               from transfemoral access have not been studied, and tortuosity and calcification of the ileo-femoral axis
               could reduce the ability of Hat marker orientation.


                                                                                          [22]
               Patient- and device-specific implantation techniques were evaluated by Bieliauskas et al.  in an analysis of
               60 consecutive patients treated with three different self-expanding THV platforms (Evolut, 20; Acurate-
               neo2, 20; Portico, 20). The authors obtained optimal commissural alignment in 60% of cases with equal or
               less than mild misalignment in 88% of cases. Specifically, for all three platforms, the same implantation
               sequence was followed. After inserting the system with a flush port at 3 o’clock for Evolut, 6 o’clock for
               Acurate, and 12 o’clock for Portico, the valve was positioned at the level of the anulus in a cusp overlap
               view. Then, the THV orientation was assessed and, if needed, a slow rotation of delivery catheter was
               performed to obtain a CF position of the Hat marker for Evolut or to isolate on the right one of the THV
               markers for Acurate and Portico .
                                          [22]
   88   89   90   91   92   93   94   95   96   97   98